MedTrace Logo

Pharmacokinetics Study of Gamma-aminobutyric Acid

NCT01917760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2015-11-02

No results posted yet for this study

Summary

The purpose of this study is to determine upon administering GABA orally to a person how it is absorbed, distributed, as well as the drug's pharmacological effects on the body such as glucose levels, serum C-peptide and/or insulin levels (referred to as pharmacokinetics/pharmacodynamics). We will conduct experiments in normal subjects to address these questions.

Conditions

Sponsors & Collaborators

  • Unity Health Toronto

    collaborator OTHER

  • University of Florida

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • Huashan Hospital

    lead OTHER

Principal Investigators

  • Yiming Li · Huashan Hospital

  • Qinghua Wang · Huashan Hospital/St Michael's Hospital

  • Zheng Jiao · Huashan Hospital

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-07-31
Completion
2014-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01917760 on ClinicalTrials.gov